Omnigence Asset Management
Home
About
Team
Data Science
Insights & News
Contact
Farmland
OVERVIEW
TEAM
UPDATES

Veripath Partners: Our Canadian farmland investment fund focuses on non-operated row crop farmland with productivity pricing discounts, positive productivity trends and low productivity volatility. Veripath provides consistent returns with infrequent drawdowns, low return volatility and can be an effective public equity replacement in traditional portfolios.

Private Equity
OVERVIEW
TEAM
UPDATES
PORTFOLIO

Arvore Partners: Our private equity vertical invests in the lower market where cashflow can be acquired at compelling multiples, then serially consolidated in selected verticals to drive exits. Arvore provides monthly distributions and recurring equity optionality within an evergreen offering.

Multi-Asset
OVERVIEW
TEAM
UPDATES

Genivent Partners: Our multi-asset vertical opportunistically invests in Omnigence partners funds’ secondaries and GP holdings. Genivent acts as a dedicated liquidity sleeve for investors seeking intra-hold period liquidity.

OVERVIEW
TEAM
UPDATES

Veripath Partners: Our Canadian farmland investment fund focuses on non-operated row crop farmland with productivity pricing discounts, positive productivity trends and low productivity volatility. Veripath provides consistent returns with infrequent drawdowns, low return volatility and can be an effective public equity replacement in traditional portfolios.

OVERVIEW
TEAM
UPDATES
PORTFOLIO

Arvore Partners: Our private equity vertical invests in the lower market where cashflow can be acquired at compelling multiples, then serially consolidated in selected verticals to drive exits. Arvore provides monthly distributions and recurring equity optionality within an evergreen offering.

OVERVIEW
TEAM
UPDATES

Genivent Partners: Our multi-asset vertical opportunistically invests in Omnigence partners funds’ secondaries and GP holdings. Genivent acts as a dedicated liquidity sleeve for investors seeking intra-hold period liquidity.

Home
About
Team
Data Science
Insights & News
Contact
Navigation menu closed
July 7, 2025

High-CostBetaMasqueradingasAlpha:TheInstitutionalIllusionofAlternativeInvestingandtheNeedtoReturntoBasics

By nhoussaine-clareLast updated February 24, 2026

Institutional investors have dramatically expanded their exposure to alternative investments, now allocating as much as 30–50% of total portfolios to private equity, hedge funds, real estate, infrastructure, and private credit. While these asset classes once offered genuine alpha through access to inefficiencies and niche strategies, they are now increasingly crowded, financialized, and expensive. This paper argues that much of what is currently labelled “alternative” is no longer truly alternative. Many institutional scale alternatives now deliver high-cost beta—returns driven by financial engineering and leverage—while charging alpha-level fees. For example, hedge funds returned just ~5% annually over the past 5 years (HFRI FWC), compared to a 60/40 stock-bond portfolio at approximately 7% (Vanguard estimate). Net-of-fee private equity performance, meanwhile, has hovered around ~10%. With dispersion declining and fee drag rising, institutional portfolios face a reckoning.

The solution lies in redirecting capital toward truly uncorrelated, under-capitalized strategies and smaller, niche managers. These strategies often demand more complex underwriting but offer the genuine diversification and return potential that alternatives once promised. View Full Report

LegalPrivacy Policy
AboutTeamData ScienceInsights & NewsContact
AI Index